Sectors
VERA
Vera Therapeutics, Inc.
34.08
1 x 22.14
2 x 38.91
bid
ask
-
0.11
0.32%
2 @ 07:57 PM
34.08 +0.00 (0.00%)
| Ytd | -32.70% | |
| 1y | 57.49% |
33.18
day range
34.38
21.64
52 week range
56.05
| Open | 33.64 | Prev Close | 34.19 | Low | 33.18 | High | 34.38 | Mkt Cap | 2.46B |
| Vol | 1.54M | Avg Vol | 2.08M | EPS | -5.87 | P/E | N/A | Forward P/E | -7.25 |
| Beta | 0.95 | Short Ratio | 8.21 | Inst. Own | 117.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 36.22 | 200-d Avg | 39.30 | 1yr Est | 77.14 |
| Income Statement | |||
| Operating Expenses | 112.49M | ||
| Research and Development Expense | 60.08M | ||
| Selling, General and Administrative Expense | 52.41M | ||
| Operating Income | -112.49M | ||
| Interest Expense | 1.85M | ||
| Net Income | -109.47M | ||
| Net Income Common Stock | -109.47M | ||
| Net Income Common Stock (USD) | -109.47M | ||
| Consolidated Income | -109.47M | ||
| Earnings per Basic Share | -1.52 | ||
| Earnings per Basic Share (USD) | -1.52 | ||
| Earnings per Diluted Share | -1.52 | ||
| Earning Before Interest & Taxes (EBIT) | -107.62M | ||
| Earning Before Interest & Taxes (USD) | -107.62M | ||
| Weighted Average Shares | 71.84M | ||
| Weighted Average Shares Diluted | 71.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 48.88M | ||
| Cash and Equivalents (USD) | 48.88M | ||
| Investments | 450.29M | ||
| Investments Current | 450.29M | ||
| Current Assets | 527.49M | ||
| Total Assets | 532.98M | ||
| Total Debt | 75.23M | ||
| Current Liabilities | 48.32M | ||
| Debt Non-Current | 75.23M | ||
| Total Liabilities | 125.23M | ||
| Accumulated Retained Earnings (Deficit) | -991.37M | ||
| Accumulated Other Comprehensive Income | -403.00K | ||
| Shareholders Equity | 407.76M | ||
| Shareholders Equity (USD) | 407.76M | ||
| Assets Non-Current | 5.49M | ||
| Total Debt (USD) | 75.23M | ||
| Liabilities Non-Current | 76.91M | ||
| Trade and Non-Trade Payables | 14.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 252.00K | ||
| Net Cash Flow from Financing | 1.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -65.47M | ||
| Capital Expenditure | -114.00K | ||
| Issuance (Purchase) of Equity Shares | 1.92M | ||
| Net Cash Flow from Investing | 32.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 32.97M | ||
| Net Cash Flow from Operations | -100.25M | ||
| Share Based Compensation | 15.86M | ||